News Overview

India Steel Works will hold a meeting of the Board of Directors of the Company on 11 January 2022

DHP India will hold a meeting of the Board of Directors of the Company on 9 February 2022

Keerti Knowledge Skills will hold a meeting of the Board of Directors of the Company on 12 January 2022

Route Mobile will hold a meeting of the Board of Directors of the Company on 27 January 2022

Hubtown has cancelled the board meeting which was scheduled to be held on 5 January 2022

Larsen Toubro has allotted 35605 equity shares under ESOS on 05 January 2022

Goblin India will hold a meeting of the Board of Directors of the Company on 13 January 2022

Reliance Industries announced that its wholly owned subsidiary Reliance New Energy Solar RNESL has acquired by way of off-market purchase 18400000 equity shares of Re 1 each at a price of Rs 375 per share aggregating to Rs 690 crore from Shapoorji Pallonji and Company one of the promoters of Sterling and Wilson Renewable Energy SWREL Consequent to such acquisition RNESL holds 2516Percentage of the […]

Alembic Pharmaceuticals today announced that it has received tentative approval from the US Food Drug Administration USFDA for its Abbreviated New Drug Application ANDA for Vortioxetine Tablets 5 mg 10 mg 15 mg and 20 mg The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product RLD Trintellix Tablets 5 mg 10 mg 15 mg and 20 mg of Takeda Pharmaceuticals USA […]

Lupin announced the launch of Molnupiravir in India under the brand name Molnulup This drug has been given emergency use authorization by the Drug Controller General of India DCGI for treatment of adult patients with Covid19 with SpO2 > 93Percentage and the ones who have a high risk of progression of the disease including hospitalization Internationally Molnupiravir is an oral antiviral that has been approved […]